CVE-2017-17678

Severity CVSS v4.0:

Pending analysis

Type:

CWE-79 Cross-Site Scripting (XSS)

Publication date:

19/05/2021

Last modified:

09/07/2026

Description

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Impact

Vector 3.x

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N CVSS v3.1 Severity and Metrics:

Base Score: 6.10 MEDIUM
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Attack Vector (AV): Network
Attack Complexity (AC): Low
Privileges Required (PR): None
User Interaction (UI): Required
Scope (S): Changed
Confidentiality (C): Low
Integrity (I): Low
Availability (A): None

Base Score 3.x

6.10

Severity 3.x

MEDIUM

Vector 2.0

AV:N/AC:M/Au:N/C:N/I:P/A:N CVSS v2.0 Severity and Metrics:

Base Score: 4.30 MEDIUM
Vector: AV:N/AC:M/Au:N/C:N/I:P/A:N

Attack Vector (AV): Network
Attack Complexity (AC): Medium
Authentication (Au): None
Confidentiality (C): None
Integrity (I): Physical
Availability (A): None